Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
Infect Dis (Lond). 2022 Nov;54(11):773-783. doi: 10.1080/23744235.2022.2092647. Epub 2022 Jul 7.
People living with human immunodeficiency virus (HIV) are more likely to develop tuberculosis (TB), and their co-infection (HIV-TB) increases the risk of death. We aimed to describe the global trends, regional differences and age distribution of HIV-TB.
Annual new cases, age-standardized incidence rates (ASRs) and age-specific incidence rates with 95% uncertainty intervals (UIs) of HIV-infected drug-susceptible tuberculosis (HIV-DS-TB), HIV-infected multidrug-resistant tuberculosis without extensive drug resistance (HIV-MDR-TB) and HIV-infected extensively drug-resistant tuberculosis (HIV-XDR-TB) during 1990-2019 were collected from the Global Burden of Disease Study 2019. To reveal the trends of HIV-TB by region and age, the percentage change of new cases and estimated annual percentage change (EAPC) of ASRs were calculated.
The ASR of HIV-XDR-TB increased significantly by an average of 14.77% (95% CI: 11.05%-18.62%) per year during 1990-2019 worldwide, while the ASRs of HIV-DS-TB and HIV-MDR-TB decreased after 2005. HIV-XDR-TB was a great threat to Eastern Europe for the largest number of new cases (792, 95% UI: 487-1167) and the highest ASR (0.34 per 100,000 population, 95% UI: 0.21-0.50). In addition, Oceania had the largest rise in ASRs of HIV-MDR-TB (EAPC = 22.56, 95% CI: 18.62-26.64) and HIV-XDR-TB (EAPC = 32.95, 95% CI: 27.90-38.20) during 1990-2019. Recently, age-specific incidence rates of HIV-XDR-TB increased in all age groups, especially in the 50-69 age groups among high, low-middle and low Socio-Demographic Index regions. Additionally, the proportion of patients aged <15 years was nearly 10% of new cases in sub-Saharan Africa in 2019, which was higher than in other regions.
HIV-infected drug-resistant TB is common in Oceania and Eastern Europe. Moreover, HIV-XDR-TB among elderly people became increasingly prevalent. In the future, the collaboration of management for HIV and TB should be intensified in Oceania and Eastern Europe, and more concerns need to be paid in elderly people.
人类免疫缺陷病毒(HIV)感染者更易罹患结核病(TB),且 HIV 与 TB 的双重感染(HIV-TB)会增加死亡风险。本研究旨在描述全球 HIV-TB 的流行趋势、地区差异和年龄分布。
从 2019 年全球疾病负担研究中收集了 1990-2019 年期间 HIV 感染者中对药物敏感的结核(HIV-DS-TB)、HIV 感染者中对药物耐药的结核(HIV-MDR-TB,不包括广泛耐药结核)和 HIV 感染者中广泛耐药结核(HIV-XDR-TB)的每年新发病例数、年龄标准化发病率(ASR)以及 95%置信区间(CI)和年龄特异性发病率。为了揭示按地区和年龄划分的 HIV-TB 趋势,计算了新发病例百分比变化和 ASR 的估计年百分比变化(EAPC)。
1990-2019 年期间,全球范围内 HIV-XDR-TB 的 ASR 平均每年显著增加 14.77%(95%CI:11.05%-18.62%),而 HIV-DS-TB 和 HIV-MDR-TB 的 ASR 在 2005 年后下降。东欧的 HIV-XDR-TB 新发病例数最多(792 例,95%UI:487-1167),ASR 最高(0.34/10 万人口,95%UI:0.21-0.50),因此 HIV-XDR-TB 对东欧构成了巨大威胁。此外,大洋洲的 HIV-MDR-TB(EAPC = 22.56,95%CI:18.62-26.64)和 HIV-XDR-TB(EAPC = 32.95,95%CI:27.90-38.20)的 ASR 增长最大。最近,所有年龄组的 HIV-XDR-TB 的年龄特异性发病率都有所增加,尤其是高、中低和低社会人口指数地区的 50-69 岁年龄组。此外,2019 年撒哈拉以南非洲地区年龄<15 岁的患者比例接近新发病例的 10%,高于其他地区。
大洋洲和东欧地区 HIV 感染者中耐药性结核较为常见。此外,老年人中 HIV-XDR-TB 的发病率也呈上升趋势。未来,大洋洲和东欧地区应加强对 HIV 和 TB 管理的合作,对老年人应给予更多关注。